| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |